Blogs
Lilly Receives FDA Approval for Schizophrenia Drug -- Seeking Alpha
<strong><a href="http://register.zacks.com/ucd/step1.php?ALERT=alpha&ADID=ALPHA_content_welcome">Zacks.com</a>submits:</strong><p>Recently,<strong>Eli Lilly</strong>(<a href='http://seekingalpha.com/symbol/lly' title='More opinion and analysis of LLY'>LLY</a>) received US Food and Drug
ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call -- Seeking Alpha
<p>ACADIA Pharmaceuticals, Inc. (<a href='http://seekingalpha.com/symbol/acad' title='More opinion and analysis of ACAD'>ACAD</a>)</p><p>Q3 2009 Earnings Call</p><p>November 9, 2009 17:00 p.m. ET</p><br/><a
Vanda Pharmaceuticals: Heavily Undervalued -- Seeking Alpha
<p>Vanda Pharmaceuticals (<a href='http://seekingalpha.com/symbol/vnda' title='More opinion and analysis of VNDA'>VNDA</a>) is making a stunning come back this year as FDA finally approved its schizophrenia drug Fanapt. But the story is far from over, and<img
Page:
